NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year over year increase in its fiscal fourth quarter revenues and a 6 percent increase in fiscal year 2018 revenues.

For the quarter ended Sept. 30, the diagnostics manufacturer reported revenues of $53.1 million compared to $49.7 million in the prior year, beating analysts' consensus estimate of $51.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.